Carpenter D, Balleisen E, Moss D. “Confidence Games: How Does Regulation Constitute Markets?”. In: Towards a New Theory of Regulation. New York : Cambridge University Press ; 2009.
Carpenter D. “Adaptive Signal Processing Hierarchy and Budgetary Control in Federal Regulation”. American Political Science Review . 1996;90 (2) :283-302.
Carpenter D. “Reputation Information and Confidence – The Political Economy of Pharmaceutical Regulation”. Public Choice and Public Law . 2010.
Carpenter D, Meier K, Krause G. Why Do Bureaucrats Delay? Lessons from a Stochastic Optimal Stopping Model of Product Approval” forthcoming. 2003.
Carpenter D, Moffitt S, Moore C, Rynbrandt R, Ting M, Yohai I, Zucker EJ. Early-Entrant Protection in Approval Regulation: Theory and Evidence from FDA Drug Review. Journal of Law Economics and Organization . 2010;26 (2).
Carpenter D. Groups the Media Agency Waiting Costs and FDA Drug Approval. American Journal of Political Science. 2002;46 (2) :490-505.
Carpenter D, Grimmer J, Lomazoff E. “Approval Regulation and Endogenous Consumer Confidence: Theory and an Analogies to Licensing, Safety and Financial Regulation”. Regulation and Governance . 2010;4 (4).
Carpenter D. “Protection without Capture: Dynamic Product Approval by a Politically Responsive Learning Regulator”. American Political Science Review . 2004;98 (4) :613-631. protwoc-apsr-pub.pdf
Carpenter D, Ting M. “Regulatory Errors with Endogenous Agendas”. American Journal of Political Science . 2007;51 (4) :835-853. regulatory_error_with_endogenous_agendas_-_ajpspublished.pdf
The Petition and Republican Government [NEH Digitization Project on Digitization of Massachusetts Anti-Slavery Petitions]